Follow-The-Filings

Security · featured owners

BAX Baxter Intl Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 8 Owners
  • #122
  • Max 4.1%
  • Master 0.18%
  • $3.1B
  • 4 add 4 reduce

BAX (Baxter Intl Inc.) is held in 8 featured 13F books as of 2026 Q2. Richard Pzena - Pzena Investment Management is the largest tracked holder by portfolio weight (4.1%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 4.1% (Richard Pzena - Pzena Investment Management) · not free-float ownership

  1. Richard Pzena add 4.1%
  2. Hillman Capital Management reduce 3.6%
  3. Greenhaven Associates reduce 3.5%
  4. First Pacific Advisors add 2.0%
  5. Dodge & Cox add 0.65%
  6. Murphy Pohlad add 0.45%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Richard Pzena - Pzena Investment Management 2026 Q2 4.1% Add +1.2% 65,295,393 $1.4B history
Dodge & Cox 2026 Q2 0.65% Add +2.0% 58,386,345 $1.2B history
Greenhaven Associates 2026 Q2 3.5% Reduce −0.2% 14,285,228 $305M history
First Pacific Advisors 2026 Q2 2.0% Add +13.7% 7,618,145 $162M history
Hillman Capital Management 2026 Q2 3.6% Reduce −4.6% 236,032 $5M history
Murphy Pohlad - Murphy Pohlad Asset Management 2026 Q2 0.45% Add +12.5% 60,401 $1M history
Mairs & Power 2026 Q2 <0.01% Reduce −44.4% 12,532 $267K history
Tweedy, Browne Co. 2026 Q2 0.02% Reduce −2.7% 9,479 $202K history

8 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 14 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,5.03,5.07,9.01 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 9 rows shown

Filed Form Detail Links
4 Period Sep 2, 2026 · 2 forms Filing Doc
4 Period Sep 1, 2026 Filing Doc
4 Period Jun 2, 2026 · 2 forms Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period May 5, 2026 · 8 forms Filing Doc
4 Period Mar 6, 2026 · 5 forms Filing Doc
4 Period Feb 27, 2026 · 4 forms Filing Doc
4 Period Mar 2, 2026 Filing Doc
4 Period Feb 27, 2026 Filing Doc

Updated 10 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $14.81B $10.64B $11.24B
Gross profit $4.98B $3.98B $3.38B
Gross margin * 33.6% 37.5% 30.1%
Net income $2.66B -$0.649B -$0.957B
Net margin * 17.9% -6.1% -8.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $9.6B $8.85B $6.87B
Total non-current assets * $18.68B $16.93B $13.18B
Total assets $28.28B $25.78B $20.06B
Total current liabilities $6.5B $6.51B $2.97B
Total non-current liabilities * $13.3B $12.25B $10.98B
Total equity $8.4B $6.96B $6.13B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.73B $1.02B $0.845B
Cash from investing $3.21B -$0.626B $2.84B
Cash from financing -$3.49B -$1.08B -$4.22B
Net change in cash $1.48B -$0.784B -$0.446B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders